SINOVAC BIOTECH
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufacture... d it for the Chinese Central Government, pursuant to the government-stockpiling program. The company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), of which the EV71 vaccine is currently in Phase III clinical trials, pneumococcal conjugate, pneumococcal polysaccharides, and rubella. Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines.
SINOVAC BIOTECH
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.sinovacbio.com
Total Employee:
501+
Status:
Active
Contact:
+86 10 8289 0088
Email Addresses:
[email protected]
Total Funding:
96.33 M USD
Technology used in webpage:
Euro Pound Sterling Japanese Yen HiChina DNS Choopa
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Protalix BioTherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Zhenge Biotech
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Current Employees Featured
Founder
Stock Details
Investors List
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Sinovac Biotech
Advantech Capital
Advantech Capital investment in Post-IPO Equity - Sinovac Biotech
Spark Investment Management
Spark Investment Management investment in Post-IPO Equity - Sinovac Biotech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-15 | Sepax Technologies | Sinovac Biotech investment in Series D - Sepax Technologies | 500 M CNY |
More informations about "Sinovac Biotech"
Sinovac Biotech - Crunchbase Company Profile
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, โฆSee details»
Company-SINOVAC: Supply Vaccines to Eliminate โฆ
Corporate Social Responsibility (CSR) is one of the driving forces for sustainable development of our company. We always attach great importance to social responsibility work, actively undertake corporate social responsibility, deliver โฆSee details»
SINOVAC: Supply Vaccines to Eliminate Human โฆ
Validated by the World Health Organization's Emergency Use Listing ("EUL") Procedure on June 2, 2021 Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive ® Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive ®See details»
Sinovac Biotech - Wikipedia
Sinovac's commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella vaccine and mumps vaccine. CoronaVac is an inactivated virus COVID-19 vaccine developed by Sinovac. It has been in Phase III clinical trials in Brazil, Chile, Indonesia, Philippines, and Turkey. See details»
World Health Organization authorizes Chinaโs Sinovac Covid-19 โฆ
Jun 1, 2021 The World Health Organization (WHO) has authorized a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use. The decision will allow โฆSee details»
The World Health Organization authorizes the ... - The New York โฆ
Jun 1, 2021 The World Health Organization has cleared a Covid-19 vaccine made by the Chinese pharmaceutical company Sinovac for emergency use, opening the way for it to be โฆSee details»
Sinovac Company Profile 2024: Stock Performance & Earnings
Sinovac General Information Description. Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and โฆSee details»
Sinovac Biotech - Craft
Sinovac Biotech (also known as ๅไบฌ็งๅ ด) is a biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of vaccines that protect against โฆSee details»
WHO approves Sinovac Covid-19 vaccine for emergency use
Jun 1, 2021 A Covid-19 vaccine by Chinaโs Sinovac Biotech has been approved for emergency use by the World Health Organization, adding a globally recognised vote of confidence to a jab โฆSee details»
SINOVAC's Vital Role in the Belt and Road Initiative: A Lifeline in โฆ
October 20, 2023, Beijing, China โ Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today shared its โฆSee details»
Sinovac Announced Buildup of Two Billion Annual Capacity of Its โฆ
Apr 1, 2021 The facility and quality management system of CoronaVac has been inspected by China, Brazil, Indonesia, Chile, Singapore, and Saudi Arabia, as well as the World Health โฆSee details»
Sinovac banks on localization for global edge - Chinadaily.com.cn
Oct 25, 2023 Sinovac banks on localization for global edge Riding BRI, vaccine giant seeks more cooperation with overseas partnersSee details»
Covid: China's Sinovac vaccine gets WHO emergency approval - BBC
Jun 1, 2021 The World Health Organization (WHO) has approved China's Sinovac Covid vaccine for emergency use. The WHO said it prevented symptomatic disease in 51% of those โฆSee details»
WHO validates Sinovac COVID-19 vaccine for emergency use and โฆ
Jun 1, 2021 WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it โฆSee details»
Interim recommendations for use of the inactivated COVID-19 โฆ
Mar 15, 2022 Overview . These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of โฆSee details»
Background document on the inactivated vaccine Sinovac โฆ
Jun 1, 2021 Overview This background document on the Sinovac-CoronaVac vaccine was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of โฆSee details»
Pipeline-SINOVAC: Supply Vaccines to Eliminate Human Diseases
SINOVAC upholds a diversified product pipeline and a continuous process of innovation to support its aims to develop safer and more effective vaccines that provide protection from โฆSee details»
The Sinovac-CoronaVac COVID-19 vaccine: What you need to know
Updated on 10 June 2022 pursuant to revised interim recommendations. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim policy โฆSee details»
Evidence Assessment: Sinovac/CoronaVacCOVID-19 vaccine
Apr 5, 2021 2 EVIDENCE ASSESSMENT: CoronaVacCOVID-19 vaccine Key evidence to inform policy recommendations on the use of CoronaVac Background โข 2-dose ฮฒ-propiolactone โฆSee details»
WHO validates Sinovac COVID-19 vaccine for emergency use and โฆ
Jun 17, 2021 Interim recommendations for the use of COVID-19 vaccine inactivated, CoronaVac, developed by SinovacOn 1 June 2021, the World Health Organization (WHO) has โฆSee details»